ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GMX Reliance Gen.

0.55
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Reliance Gen. LSE:GMX London Ordinary Share GB00B1MM9925 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.55 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Reliance GeneMedix PLC AGM Confirmation of Delisting (4616N)

28/09/2012 12:30pm

UK Regulatory


Reliance Genemedix (LSE:GMX)
Historical Stock Chart


From Nov 2019 to Nov 2024

Click Here for more Reliance Genemedix Charts.

TIDMGMX

RNS Number : 4616N

Reliance GeneMedix PLC

28 September 2012

FOR IMMEDIATE RELEASE 28 September 2012

Reliance GeneMedix plc

(AIM: GMX)

Result of AGM

The board of Reliance GeneMedix plc ("Reliance GeneMedix" or the "Company") announces that at the Annual General Meeting of the Company's shareholders held today all resolutions were duly passed including those to cancel the admission to trading on AIM of the Ordinary Shares and to re-register the Company as a private limited company. Consequently, it is expected that the last day of dealings in the Ordinary Shares on AIM will be 5 October 2012 and it is expected that the cancellation of admission to trading on AIM of the Ordinary Shares will take effect from 7.00a.m. (British Summer Time) on 8 October 2012. The earliest date that the Company will be re-registered as a private limited company is expected to be 26 October 2012.

If Shareholders wish to buy or sell Ordinary Shares on AIM they must do so prior to the De-Listing becoming effective.

If any of the above dates change, the revised dates will be notified to Shareholders by a further announcement through a Regulatory Information Service. Unless otherwise defined, terms used in this announcement have the meaning given to them in the circular sent to Shareholders on 5 September 2012.

In accordance with AIM Rule 26, a copy of this announcement is available on the Company's website at www.genemedix.com.

ENQUIRIES:

 
 Reliance GeneMedix plc                  Tel: +353 57 932 3572 
 Vinay Ranade, Chief Executive Officer 
 
 Deloitte Corporate Finance              Tel: 020 7936 3000 
 Jonathan Hinton, John Ball 
 
 Lothbury Financial Services             Tel: 020 7868 2567 
 Michael Padley 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCGMGZLMRNGZZM

1 Year Reliance Genemedix Chart

1 Year Reliance Genemedix Chart

1 Month Reliance Genemedix Chart

1 Month Reliance Genemedix Chart

Your Recent History

Delayed Upgrade Clock